Literature DB >> 24045942

Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis.

Jayshree Mishra1, Raj K Verma, Gianfranco Alpini, Fanyin Meng, Narendra Kumar.   

Abstract

Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase expressed in both hematopoietic and nonhematopoietic cells. Previously, we characterized the functions of Jak3 in cytoskeletal remodeling, epithelial wound healing, and mucosal homeostasis. However, the role of Jak3 in mucosal differentiation and inflammatory bowel disease was not known. In this report, we characterize the role of Jak3 in mucosal differentiation, basal colonic inflammation, and predisposition toward colitis. Using the Jak3 knock-out (KO) mouse model, we show that Jak3 is expressed in colonic mucosa of mice, and the loss of mucosal expression of Jak3 resulted in reduced expression of differentiation markers for the cells of both enterocytic and secretory lineages. Jak3 KO mice showed reduced expression of colonic villin, carbonic anhydrase, secretory mucin muc2, and increased basal colonic inflammation reflected by increased levels of pro-inflammatory cytokines IL-6 and IL-17A in colon along with increased colonic myeloperoxidase activity. The inflammations in KO mice were associated with shortening of colon length, reduced cecum length, decreased crypt heights, and increased severity toward dextran sulfate sodium-induced colitis. In differentiated human colonic epithelial cells, Jak3 redistributed to basolateral surfaces and interacted with adherens junction (AJ) protein β-catenin. Jak3 expression in these cells was essential for AJ localization of β-catenin and maintenance of epithelial barrier functions. Collectively, these results demonstrate the essential role of Jak3 in the colon where it facilitated mucosal differentiation by promoting the expression of differentiation markers and enhanced colonic barrier functions through AJ localization of β-catenin.

Entities:  

Keywords:  Colitis; Differentiation; Inflammatory Bowel Disease; Innate Immunity; Jak Kinase; β-Catenin

Mesh:

Substances:

Year:  2013        PMID: 24045942      PMCID: PMC3814773          DOI: 10.1074/jbc.M113.504126

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Live and let die in the intestinal epithelium.

Authors:  Elena Sancho; Eduard Batlle; Hans Clevers
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

2.  Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines.

Authors:  I Chantret; A Barbat; E Dussaulx; M G Brattain; A Zweibaum
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

3.  Laboratory performance in albumin and total protein measurement using a commutable specimen: results of a College of American Pathologists study.

Authors:  Stanley F Lo; W Greg Miller; Basil T Doumas
Journal:  Arch Pathol Lab Med       Date:  2013-07       Impact factor: 5.534

4.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

5.  The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice.

Authors:  Yukie Murata; Akira Yamashita; Takashi Saito; Kazuo Sugamura; Junji Hamuro
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

6.  p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.

Authors:  Jose Piedra; Susana Miravet; Julio Castaño; Héctor G Pálmer; Nora Heisterkamp; Antonio García de Herreros; Mireia Duñach
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

Authors:  H Mashimo; D C Wu; D K Podolsky; M C Fishman
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

8.  Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.

Authors:  Holger Sann; Jasmin von Erichsen; Manuela Hessmann; Andreas Pahl; Angelika Hoffmeyer
Journal:  Life Sci       Date:  2013-02-08       Impact factor: 5.037

9.  The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation.

Authors:  Yinghua Xu; Nicholas H Hunt; Shisan Bao
Journal:  Cell Res       Date:  2008-12       Impact factor: 25.617

10.  Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis.

Authors:  P Kosa; R Szabo; A A Molinolo; T H Bugge
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

View more
  19 in total

1.  Adapter protein Shc regulates Janus kinase 3 phosphorylation.

Authors:  Jayshree Mishra; Narendra Kumar
Journal:  J Biol Chem       Date:  2014-05-02       Impact factor: 5.157

2.  JAK3 restrains inflammatory responses and protects against periodontal disease through Wnt3a signaling.

Authors:  Lanhai Lü; Lan Yakoumatos; Junling Ren; Xiaoxian Duan; Huaxin Zhou; Zhen Gu; Muddasir Mohammed; Silvia M Uriarte; Shuang Liang; David A Scott; Richard J Lamont; Huizhi Wang
Journal:  FASEB J       Date:  2020-05-20       Impact factor: 5.191

Review 3.  Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.

Authors:  Clara Abraham; Parambir S Dulai; Séverine Vermeire; William J Sandborn
Journal:  Gastroenterology       Date:  2016-10-22       Impact factor: 22.682

4.  Null Function of Npr1 Disturbs Immune Response in Colonic Inflammation During Early Postnatal Stage.

Authors:  Changkun Long; Hongfei Liu; Wenxing Zhan; Liping Chen; Andong Wu; Lin Yang; Shenghan Chen
Journal:  Inflammation       Date:  2022-07-07       Impact factor: 4.092

Review 5.  Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.

Authors:  Clara Abraham; Maria T Abreu; Jerrold R Turner
Journal:  Gastroenterology       Date:  2022-02-09       Impact factor: 33.883

6.  JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold Determines Innate Receptor-Induced Proinflammatory Cytokine Secretion in Macrophages.

Authors:  Matija Hedl; Deborah D Proctor; Clara Abraham
Journal:  J Immunol       Date:  2016-09-23       Impact factor: 5.422

Review 7.  JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.

Authors:  Azucena Salas; Cristian Hernandez-Rocha; Marjolijn Duijvestein; William Faubion; Dermot McGovern; Severine Vermeire; Stefania Vetrano; Niels Vande Casteele
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-19       Impact factor: 46.802

8.  Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome.

Authors:  Jayshree Mishra; Raj K Verma; Gianfranco Alpini; Fanyin Meng; Narendra Kumar
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

9.  Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.

Authors:  Jayshree Mishra; Randall Simonsen; Narendra Kumar
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

10.  Helicobacter hepaticus Induce Colitis in Male IL-10-/- Mice Dependent by Cytolethal Distending Toxin B and via the Activation of Jak/Stat Signaling Pathway.

Authors:  Liqi Zhu; Chen Zhu; Shuyang Cao; Quan Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-12       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.